Managing acute respiratory infection outbreaks in care homes: A cross-sectional study of public health response across South East England Authors: Shyun Ping Tiong, Branagh Crealock-Ashurst, Jason Yun, Anjali Pai, Natalie Adams, Simon Ferris Published: 2026 ABSTRACT BackgroundAcute respiratory infection (ARI) outbreaks in care homes remain a significant burden, especially during influenza season. Prompt public health responses and timely antiviral administration are crucial for mitigating transmission and minimising the impacts of outbreaks. This study aimed to assess the timeliness and appropriateness of the public health response to notifications of ARI in care homes during flu season, across the South East England region.MethodsThis was a cross-sectional study analysing ARI in care home notifications during 2024/25 Chief Medical Officer (CMO)-declared flu season. A combination of quota and random sampling was used for detailed analysis. Descriptive and inferential statistical analyses were used to evaluate timeliness of public health response and antiviral prescribing patterns.ResultsDuring the study period, 340 ARI incidents were notified among 2737 care homes, and 103 care homes were included in the detailed analysis. The median time from first symptom onset to public health notification was 4 days (IQR 3–7 days), whereas the median time from most recent reported symptom onset to public health assessment was 1 day (IQR 0–1 day), indicating a prompt public health response following outbreak notification. The median time interval from risk assessment to antiviral recommendation was the same day. Prior to public health assessment, 66/82 (80.5%) care homes reviewed by a GP had residents commenced on antibiotics, 4/82 (4.9%) on antivirals, and 7/82 (8.5%) on both antibiotics and antivirals.ConclusionOur findings suggest that public health response following notification of ARI outbreaks in care homes was generally prompt. However, delays in outbreak recognition and notification, barriers to timely antiviral prescribing, and frequent antibiotic prescribing despite influenza-like illness criteria being met highlight the need to streamline antiviral prescribing pathways and strengthen antimicrobial stewardship in this setting. Introduction Acute respiratory infection (ARI) outbreaks in care homes remain a significant public health challenge. This is of particular concern as residents in these settings are more vulnerable to complications due to their overall frailty, comorbidities, shared caregivers and communal living environment (Childs et al., 2019; Furman et al., 2004; Lansbury et al., 2017). ARIs are a major cause of hospitalisation and death among older adults, contributing to 28 hospitalisations and 15 deaths per 1000 persons, resulting in a considerable strain on healthcare resources (Ellis et al., 2003; Lansbury et al., 2017). In the absence of effective infection prevention and control (IPC) measures, ARIs spread rapidly in care homes due to their closed settings and prolonged viral shedding in the elderly, leading to an increased attack rate of 20–40% (Booy et al., 2012; Willcox et al., 2024). Seasonal patterns play a crucial role in influenza outbreaks, with peak activity occurring during winter months from December to February in the UK, although sporadic outbreaks may occur outside of these months. Within the UKHSA, the South East Health Protection Team is responsible for managing ARI outbreaks in care homes by providing public health response within the region. This includes performing risk assessments, providing guidance on IPC measures and recommending vaccination and antiviral use as indicated to reduce the impact of outbreaks in care homes. Timely public health responses are crucial in improving outbreak management and reducing the burden of ARIs in care home populations. The objectives of this study are to evaluate the timeliness and appropriateness of the public health response to notifications of ARI in care homes during flu season, across the South East England region. Methods This study was undertaken by the South East Health Protection Team. As of December 2024, the South East had 2737 registered care homes – 18.8% of all in England, according to Department of Health and Social Care statistics (Gov.uk, 2025). This region is subdivided into four main geographical areas, including Hampshire and Isle of Wight, Thames Valley, Kent, Surrey and Sussex. This study was conducted during the Chief Medical Officer (CMO)-declared influenza season 2024/25. A CMO letter dated 03/12/2024 (CEM/CMO/2024/003) (DHSC, 2024) advised community circulation of influenza and for primary care services to consider prescribing antiviral medicines (oseltamivir and zanamivir) for prophylaxis and treatment of influenza. This was a cross-sectional study using data collected from UKHSA’s Case and Incident Management System (CIMS), a database used to record all notified cases, enquiries and incidents. Ethical approval and informed consent were not required because this evaluation used anonymised routinely collected operational data. For this study, we reviewed CIMS to identify cases and outbreaks of ARI in care home settings, between 03/12/2024 and 22/02/2025. Symptomatic cases are usually notified by care home managers and entered into CIMS as incidents. An initial risk assessment is carried out by members of the South East Health Protection Team. National guidance defines Influenza-like illness (ILI) as “temperature ≥ 37.8°C and acute onset of respiratory symptoms or acute deterioration in physical or mental ability without other cause.” It also outlines criteria on declaring an outbreak: a confirmed outbreak is defined as 2 or more confirmed cases of influenza, while a probable outbreak is considered with one case of confirmed influenza, provided there is no contradictory virological evidence from other symptomatic residents, or through judgement of a consultant or other senior health protection team staff, supported by evidence such as presence of ILI symptoms (Gov.uk, 2024). An influenza outbreak is defined using 2-day window for onset of cases because the median incubation period for influenza A is just under 2 days (Gov.uk, 2024). Figure 1 illustrates the UKHSA management pathway for ARI outbreaks in care homes.Figure 1.UKHSA management pathway for ARI outbreaks in care homes. UKHSA management pathway for ARI outbreaks in care homes. In accordance with the national guidance, care homes are advised to notify the UKHSA when an ARI outbreak is suspected. Notification is therefore not expected following the first symptomatic resident. Consequently, the interval from first symptom onset to notification includes the time required for outbreak recognition, whereas the interval from the most recent reported symptom onset to public health risk assessment more accurately reflects the timeliness of the public health response following outbreak notification (UKHSA, 2021). To ensure feasibility given the high volume of reported incidents, a combination of quota and random sampling strategy was used to select up to ten care homes from each of the four regions across South East England for each month – December, January and February during the 2024–2025 Chief Medical Officer–declared flu outbreak season. In regions with fewer than 10 reported incidents in that month, all affected care homes were included. As this study was designed as a service evaluation of public health response pathways, this sampling approach was intended to allow comparison of response pattern across regions, rather than to reflect regional care home density. The presence of ARI incidents reported among selected care homes was then used to perform further analysis on timeliness of public health response and antiviral pathways. Randomisation was performed using a research randomiser (randomizer.org). Timeliness of South East Health Protection Team’s response was defined as the number of days from first and most recent symptom onset to risk assessment and antiviral recommendation. Antiviral prescribing pathway following South East Health Protection Team recommendations was evaluated by number of care homes meeting ILI criteria and outbreak management by GP. Analyses relating to GP review were assessed through exploring patterns of antimicrobial use prior to health protection team involvement. COVID-19 testing by care homes prior to health protection team notification was also assessed to determine its impact on timeliness of public health response. Descriptive statistical analyses were used to calculate time intervals between first and most recent symptom onset, risk assessment and antiviral recommendation. Chi-square (χ2) testing was used to determine the significance of antiviral recommendation in ILI cases and initiation of antibiotics by GP with statistical significance declared at p < .05. Fisher’s exact test was used to determine the statistical association between initiation of antibiotics by GP as the expected count is lower with statistical significance at p < .05. The data were analysed using IBM SPSS Statistics V 29.0.2.0. Results During the study period in the 2024/25 flu season, the South East Health Protection Team received 340 notifications of ARI incidents in 2737 care homes (overall notification rate 12.4%). Following sampling randomisation, 103 care homes were available for further analysis. In some regions, fewer than 10 incidents were reported in each month, hence all incidents were selected for analysis – for example, Kent reported 5 incidents in December and February, while Thames Valley reported 3 incidents in February. Of the 103 outbreaks analysed, 44 had laboratory-confirmed influenza and a further 31 met ILI criteria without laboratory confirmation. Together, these 75 outbreaks were considered eligible for assessment for antiviral recommendations, while the remaining 28 outbreaks had non-specific respiratory symptoms. The median time from first symptom onset to South East Health Protection Team notification was 4 days (IQR 3–7 days). As care home notify UKHSA once an outbreak is suspected rather than after the first symptomatic resident, this interval includes the time taken for outbreak recognition. The median time from the most recent reported symptoms to risk assessment was significantly shorter at 1 day (IQR 0–1 day), suggesting that public health risk assessments were generally undertaken promptly once outbreaks had been recognised and notified. The median interval from symptom onset to antiviral recommended was a median of 5 days (IQR 3–7 days) as compared to median interval from most recent symptom onset to antiviral recommended 1 day (IQR 0–1 day). The median interval from risk assessment to antiviral recommendation was the same day, indicating prompt decision making and action by the South East Health Protection Team. Figure 2 illustrates the time intervals between ARI symptom onset, South East Health Protection Team notification and antiviral recommendations.Figure 2.Box plots illustrating the time intervals associated with ARI outbreaks notification and subsequent antiviral recommendations. Box plots illustrating the time intervals associated with ARI outbreaks notification and subsequent antiviral recommendations. 82 out of 103 care homes (79.6%) were reviewed by a GP prior to notification (Table 1).Table 1.GP action prior to public health notification, stratified by ILI criteria.GP action prior toCare homes meeting ILI criteriaCare homes not meeting ILI criteriaPercentage of care homes meeting ILI criteria which received each treatment (%)Antibiotics only452176.3Antiviral only406.8Antibiotic + Antiviral7011.9Supportive treatment only325.1 Table 1.GP action prior to public health notification, stratified by ILI criteria.GP action prior toCare homes meeting ILI criteriaCare homes not meeting ILI criteriaPercentage of care homes meeting ILI criteria which received each treatment (%)Antibiotics only452176.3Antiviral only406.8Antibiotic + Antiviral7011.9Supportive treatment only325.1 GP action prior to public health notification, stratified by ILI criteria. Among incidents reviewed, 66 care homes (80.5%) received antibiotics before the health protection team risk assessment, 4 care homes (4.9%) had received antivirals and 7 care homes (8.5%) received both antibiotic and antiviral and the rest were for supportive treatment. Among 66 incidents started on antibiotics only, 45 of them (68.2%) met ILI criteria. This finding reflects the predominance of antibiotic use over antiviral therapy in early management of ARI outbreaks in care home prior to public health involvement. Among care homes with either laboratory-confirmed influenza or meeting ILI criteria, 55 out of 75 incidents (73.3%) were recommended antivirals, while none of the 28 incidents not meeting ILI criteria had antivirals recommended (χ2 = 44.061, p < .001). Antivirals were not recommended to care homes that were either outside of treatment window or only had a single case notified in accordance with the national guidance and were therefore ineligible for antivirals. Issues with antiviral arrangements were reported in 15 out of 55 incidents (27.3%). Among these, the most common reason was delays in GP prescribing (46.7%), followed by out-of-hours pharmacy stock issues (20%), integrated-care board arrangements (20%) and issues involving both pharmacy and the integrated-care board (13.3%). COVID-19 testing was conducted in 36.9% of incidents prior to risk assessments (Table 2). The main reason for not conducting test was difficulty in acquiring test kits.Table 2.Timing of conducting COVID-19 lateral flow diagnostic test following health protection team advice.Conduct LFT after UKHSA advice% (count)Same day73.8% (48)Delayed (1+ days)21.5% (14)Not done4.6% (3)Note. 38 (36.9%) of total care homes conducted COVID-19 lateral flow diagnostic tests prior to UKHSA notification and are excluded from this breakdown. Table 2.Timing of conducting COVID-19 lateral flow diagnostic test following health protection team advice.Conduct LFT after UKHSA advice% (count)Same day73.8% (48)Delayed (1+ days)21.5% (14)Not done4.6% (3)Note. 38 (36.9%) of total care homes conducted COVID-19 lateral flow diagnostic tests prior to UKHSA notification and are excluded from this breakdown. Timing of conducting COVID-19 lateral flow diagnostic test following health protection team advice. Note. 38 (36.9%) of total care homes conducted COVID-19 lateral flow diagnostic tests prior to UKHSA notification and are excluded from this breakdown. IPC advice was given to all (100%, n = 103) the care homes with reported ARI incidents. Infection prevention measures, including Personal Protective Equipment (PPE), isolation of symptomatic residents, enhanced cleaning protocols, staff cohorting, home closure, and suspending communal activities were recommended to prevent further transmission (ECDC, 2023; Gov.uk, 2024). Discussion This study found that, despite prompt responses by the health protection team, delays in outbreak notification and systematic barriers within antiviral prescribing pathway limited the timeliness and effectiveness of outbreak management in care homes across South East England. Surveillance reports from NHS England and UKHSA have previously shown that ARIs are one of the most common reasons for emergency attendance and admission (NHSE, 2024). The findings from this study underscore the importance of timely public health interventions in managing ARI outbreaks. The median interval of 4 days from first symptom onset to notification should be interpreted in the context of national guidance, which recommends notifying the health protection team when an outbreak is suspected rather than after the first ARI case. As outbreaks are defined by two or more epidemiologically linked cases, this interval incorporates the time required for additional cases to occur and for staff to recognise that an outbreak may be occurring. In some instances, the care home did promptly inform the South East health protection team upon detecting a second case. In contrast, the median interval of 1 day from most recent reported symptom onset to public health assessment indicates a prompt public health response to ARI outbreaks. This study identified a high rate of antiviral recommendations among care homes meeting ILI criteria following a South East Health Protection Team risk assessment, with antivirals recommended for 73.3% of eligible care homes. In certain incidents, antivirals were not recommended as notification of ILI had occurred outside of the effective treatment window for prescription. It is also important to note that antivirals were not recommended to any care home not meeting ILI criteria. Despite national guidance supporting the use of antivirals in ILI outbreaks, a previous study has found that the implementation of antivirals was faced with some resistance within the healthcare community (UKHSA, 2021). A total of 15 out of 55 (27.3%) of care homes reported difficulties in obtaining antivirals promptly, which could have led to missed treatment windows. Key barriers included delays in GP prescribing, particularly out-of-hours availability, limited availability of antivirals in local pharmacies and delays in ICB authorisation. These systemic challenges to prescribing highlighted a clear need to streamline antiviral prescribing pathway (Willcox et al., 2024). UKHSA has published guidance on the use of antiviral agents for influenza, outlining the dose, indications of antivirals and the role of clinicians in prescribing them (Gupta et al., 2022). However, there is no national guidance on antiviral prescribing pathways, leading to regional variation and inconsistency. Addressing this issue could be achieved by improving communication between stakeholders, developing clearer guidelines and escalation pathways at a national level. Most incidents (79.6%) had GP reviews prior to health protection team notification, underscoring the crucial role of primary care in preventing and managing outbreaks. Among incidents reviewed by GPs, 80.5% were started on antibiotics and 8.5% received antivirals, suggesting a reliance on antibiotics within these settings, despite the high prevalence of ARI of viral aetiology, particularly during the influenza season. In the incidents where antibiotics were started, 68.2% met ILI criteria which would indicate a recommendation for antiviral therapy. These findings suggest that GPs more often prescribed antibiotics, even in the context of a likely influenza outbreak. This prescribing trend can lead to inappropriate use of antibiotics for influenza, contributing to antimicrobial resistance. Targeted antimicrobial stewardship and guidance should be initiated prior to influenza season to prevent overuse of antibiotics (Yip et al., 2018). Education to raise awareness among GPs could help address this issue. The use of lateral-flow assays for influenza has been shown to have high sensitivity and specificity (Han et al., 2020) and could be valuable in supporting diagnosis and treatment decisions through point-of-care (POC) testing. National guidance recommended early rapid turnaround diagnostic virological testing, including multiplex lateral flow diagnostic tests (COVID-19, Influenza A&B, RSV) to support appropriate outbreak management (Gov.uk, 2024). POC testing could prevent antibiotic overuse due to difficulties in diagnosis in adults with ARI and support the timely initiation of antiviral therapy (Fjelltveit et al., 2022). Nevertheless, the underutilisation of antivirals by primary care in ILI cases highlighted a gap in translating national guidance into clinical practice. Despite efforts made in the South East to encourage care homes to stockpile lateral flow diagnostic tests, the testing rate remained suboptimal at 36.9% prior to risk assessment with a further 13.4% of care homes performing tests after advice from the health protection team. This could be due to difficulties obtaining the stocks from the pharmacy. Although national guidance recommends multiplex testing for COVID-19, influenza A and B, and respiratory syncytial virus during ARI outbreaks, the CIMS data did not distinguish between COVID-19 and multiplex testing. During the study period, free testing provided locally by the Integrated Care Board comprised COVID-19 test kits only, which may have limited the use of multiplex testing in participating care homes. Since completion of this study, combined respiratory virus testing has been introduced locally across South East England, which may facilitate early differentiation of influenza and COVID-19 to enable early intervention. Pre-notification testing alongside prompt outbreak notification is essential in facilitating effective and timely public health responses, such as arranging antivirals (ECDC, 2023). The UKHSA national guidance (Gov.uk, 2024) has established the importance of informing health protection team of a suspected outbreak in a timely manner, within a pragmatic 5-day window for all respiratory viruses, noting that median incubation for influenza is shorter at 2 days. Prompt outbreak notification is essential to facilitate effective public health response and reduce impacts of the outbreak. NICE guidelines have advised that antivirals such as oseltamivir and zanamivir need to be started within 48 hours of symptoms onset. Timely initiation of antiviral treatment has been shown to be associated with better clinical outcomes. One previous pairwise meta-analysis of 90 studies has found that early treatment compared with late, or no treatment was significantly associated with reduced mortality (18–20). It is, however, difficult to implement in practice and a delay over 5 days may have reduced the ability to prevent complications or transmission. The interval from risk assessment to anviral recommendation (median 0 days) was substantially shorter than the interval from first symptom onset to antiviral recommendation (median 5 days), suggesting prompt action by health protection team once an influenza outbreak is identified. Although this study was conducted within a single UKHSA region, many of the barriers identified are organisational rather than location-specific. Delays in antiviral prescribing, variation in prescribing arrangements between integrated care boards, access to out-of-hours pharmacy services and challenges in recognising and reporting outbreaks are likely to be relevant to other regions operating within similar NHS systems. While local service configuration may influence the magnitude of these delays, the findings highlight broader opportunities to strengthen national antiviral pathways, improve access to recommended testing and support antimicrobial stewardship in primary care, especially across care home settings. However, this retrospective observational study used data collected from CIMS, which may introduce recall bias, depending on accurate documentation from the health protection team at the time of risk assessment. There were a few incomplete data entries that could influence the analysis. However, this is minimised as health protection teams across the region used a standardised risk assessment proforma which reduces inconsistency and is suggested to be completed contemporaneously. This study’s sampling strategy could lead to selection bias, although this was mitigated by a combination of quota and random sampling to include fair representation from all regions and a random element to improve reliability. This study only evaluated the timeliness of antiviral recommendations by the health protection team following risk assessment but did not evaluate whether residents ultimately received antivirals. While health protection team is responsible for recommending antiviral in the management of ARI outbreaks, the authority to prescribe them lies with the Integrated Care Board or primary care providers. This study is appropriate for identifying pathway barriers and operational patterns, rather than estimating incidence or making prevalence claims. Future research could investigate the clinical outcomes of ARI outbreaks in care home such as hospitalisation, mortality rates and health impacts. The role of early antiviral use in reducing hospitalisation and complications should be evaluated to demonstrate the importance of streamlining antiviral prescribing pathway. Further research is also needed to evaluate the feasibility and cost-effectiveness of supplying POC influenza testing compared to starting antivirals in ILI cases. Notably, the NHS continues to provide free COVID-19 lateral flow diagnostics tests to eligible individuals. Given this existing service and pathway, NHS could consider supplying combined influenza and COVID-19 lateral flow diagnostic test to facilitate timely influenza diagnosis and antiviral prescribing. Education to raise awareness among healthcare practitioners about recognising ILI symptoms and initiating timely antiviral treatment and prophylaxis should be strengthened to improve outcomes during ARI outbreaks in care homes. This evaluation identified several opportunities to improve the management of ARI outbreaks in care homes. Earlier recognition of outbreaks and prompt notification to UKHSA may facilitate more timely public health interventions. Streamlining antiviral prescribing pathways, improving access to respiratory diagnostic testing, and reinforcing antimicrobial stewardship may further optimise outbreak management and reduce unnecessary antibiotic prescribing. Conclusion This study highlights the barriers and operational patterns for managing ARI outbreaks in care homes across the South East of England. While the health protection team’s action was prompt, delays in recognising outbreaks and notifying the health protection team may have reduced the effectiveness of early intervention. Antiviral recommendations were consistent but prescribing issues were identified which resulted in antivirals prescribed outside of the optimal window, emphasising the need to streamline prescribing pathways and reinforce the importance of prompt antiviral administration in the community. High rates of antibiotic prescribing despite meeting ILI criteria underscore the potential benefits for POC testing and antimicrobial stewardship, while reinforcing to community healthcare providers that, particularly during the CMO-declared flu season, antivirals remain an effective treatment for ILI.